| |
Newsroom /
Medical
/
Medical
/
Neurology Devices Market to 2017
Neurology Devices Market to 2017
Global Neurology Devices Market is forecast to reach $7.2 Billion by 2017, The report also reviews the competitive landscape and a detailed analysis of the pipeline products in each category.
London,
London,
United Kingdom
(prbd.net)
15/06/2011
The global market for neurology devices is forecast to reach $7.2 billion by 2017 with a Compound Annual Growth Rate (CAGR) of 10.4% from 2010-2017. Neurostimulation devices will remain the largest segment in the market with a value of $4.7 billion by 2017. The market is expected to be driven during the period 2010-2017 by the large patient pool suffering from neurological disorders such as epilepsy, Alzheimer’s disease, migraine, Parkinson’s syndrome, and chronic pain. Compelling clinical needs and expanding research activities on the central nervous system (CNS) will also accelerate technological innovations in neurostimulation devices and interventional neurology. Moreover, a lack of satisfaction with the first line of treatment drugs for neurological disorders will lead to increased adoption rates of neurology devices.
For Sample Pages, please click or add the below link to your browser:
http://www.gbiresearch.com/RequestSamplePages.aspx?ID=Neurology-Device-Market-to-2017-High-Potential-for-Usage-of-Neurostimulation-Devices-in-Multiple-Neurological-Disorders-to-Drive-Market-Growth&Title=Medical_Devices&ReportType=Industry_Report
According to the Parkinson's disease Foundation, Parkinson’s disease affects more than one million people in the US and more than four million people worldwide as of 2010. Out of these three million patients, around one third of patients does not respond to current treatment options and continue to experience seizures. The huge patient population affected by various neurological disorders presents huge growth opportunities for the market in the future. Moreover, there is an increased preference among patients for minimally invasive procedures which cause fewer traumas to tissues and provides a faster recovery period. This trend can be seen across the US and Europe and will boost the neurology device market. In emerging countries such as Brazil, China and India, the focus is on improving healthcare facilities through the construction of new hospitals.
GBI Research’s report, “Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth” provides key data, information and analysis on the global neurology devices market. The report provides market landscape, competitive landscape and market trends information on five neurology devices market categories – CSF management, neurosurgical products, neurostimulation devices, interventional neurology, and neurological diagnostic equipment. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and a detailed analysis of the pipeline products in each category. The report also reviews details about important merger and acquisition deals that have taken place in the neurology devices market during the past four years. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Neurology-Device-Market-to-2017-High-Potential-for-Usage-of-Neurostimulation-Devices-in-Multiple-Neurological-Disorders-to-Drive-Market-Growth&Title=Medical_Devices&ReportType=Industry_Report
Visit our report store: http://www.gbiresearch.com
For more details contact:
pressreleases@gbiresearch.com
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782
About
GBI Research is a global market intelligence services company providing information research and analysis products and services.
|